Nov 16, 2022

Proceedings from a daylong symposium hosted in partnership with Florida Cancer Specialists, featuring key clinical presentations and papers in lung cancer. Featuring perspectives from Drs Corey Langer and Christine Lovly, including the following topics:

• First-Line Treatment of Metastatic Non-Small Cell Lung...

Nov 7, 2022

Featuring a slide presentation and related discussion from Dr Rebecca Heist, including the following topics:

• Targeting MET exon 14 skipping mutations in non-small cell lung cancer (NSCLC) (0:00)
• Efficacy and tolerability of MET tyrosine kinase inhibitors in patients with NSCLC and MET alterations (12:35)
• Mechanisms of...

Nov 7, 2022

Featuring an interview with Dr Rebecca Heist, including the following topics:

• Mechanism of action and toxicity of amivantamab in patients with MET-driven non-small cell lung cancer (NSCLC) (0:00)
• Potential role of MET inhibitors as pantumor treatment for MET-altered cancer (2:27)
• Selection and sequencing of targeted...

Oct 31, 2022

Featuring perspectives from Dr Pasi Jänne, including the following topics:

• Introduction: Journal Club with Pasi A Jänne, MD, PhD — Part 1 (0:00)
• Case: An Asian man in his late 60s with adenocarcinoma of the lung and pleural effusion with EGFR amplification (PD-L1 20%) — Jennifer L Dallas, MD (12:33)
• Case: A man...

Oct 25, 2022

Featuring a slide presentation and related discussion from Dr Justin Gainor, including the following topics:

• Biology of RET Genetic Alterations in Cancer (0:00)
• Early Efforts to Target RET Alterations in Non-Small Cell Lung Cancer (NSCLC) (1:44)
• Mechanisms of Action of Selective RET Inhibitors (3:58)
• Clinical Trial...